Multiplicom, a Belgium-based biotech spin-out from the University of Antwerp has received €5.5m ($7.36m) from life science investors Gimv, PMV, Rudi Mariën, Qbic, and VIB.

GIMV, VIB and the University of Antwerp previously invested in the firm during a series A round in July 2011 which raised €2m ($2.68m).

Multiplicom, formed in 2010, said in a statement that the new funds will be used to accelerate growth. The firm specialises in the development, production, and sale of genetic tests based…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?